2:PD-1 and Apatinib

2 trials

Sponsors

Shanghai Dongfang Hospital

Conditions

Advanced Gastric Cancer

Early Phase 1

Efficacy and safety of Thymosin alpha 1 combined with anti-PD-1 and Apatinib in advanced gastric cancer patients failed to second line treatment

Active, not recruitingITMCTR1900002540

Shanghai Dongfang HospitalAdvanced Gastric Cancer

Start: 2019-08-21Updated: 2023-02-20

Efficacy and safety of Thymosin alpha 1 combined with anti-PD-1 and Apatinib in advanced gastric cancer patients failed to second line treatment

Active, not recruitingChiCTR1900025367

Shanghai Dongfang HospitalAdvanced Gastric Cancer

Start: 2019-08-21Updated: 2019-08-27